2026-10-25
NCS Multistage clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
NAS100 26,630 −6.36%
S&P 7,354 −4.36%
GOLD $4,075 −0.93%
BTC $76,040 +0.13%
VIX 26.62 −5.54%
latest tape · as of 12:04 UTC
The Screen · Energy · Oil & Gas Equipment & Services
NCS Multistage Holdings Inc
NCSM · NASDAQ · USD · Market cap $140M · 272 employees
NCS Multistage Holdings, Inc.
Not yet scored53.35 USD
Price as of 23 Oct 2026Daily close, not a live quoteLast reviewed 14 days ago
Screened 2026-10-23 · the tape above runs as of 12:04 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price53.35 USD at the 23 Oct 2026 close
- Fair valueUnder review: its inputs are 13 days old; there is no analyst estimate to cross-check it.
- Our regime readAccumulation, as of 1 Nov 2026
- Ethical screenNot yet scored
- Last reviewed23 Oct 2026 (14 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
PRICE · ONE YEAR
Our fair-value range: range not available (screen dated 2026-10-23).
- Trend Accumulation
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical screen not yet scored
Price53.35 USD
Fair valueUnder review
Ethical score70.0/100
Our investment reviews on this name
2026-09-06Read Accumulation53.35+0.0% to today ✓Markup gives way to Accumulation with volume flow in agreement
2026-07-02Read Markup54.33-1.8% to today First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
The full research record, in depth, below
This name holds its accumulation label.
NCS Multistage Holdings Inc holds its Accumulation at $53.35. The statistical read favours the sellers, held for 15 days.
| Phase | Accumulation |
| Quantitative state | The statistical read favours the sellers, held for 15 days |
| Price at the screen | $53.35 |
| Valuation | 10.80 trailing · 18.59 forward price to earnings |
| Values screen | Not scored · score 70.0 |
| Beta | 0.21 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 7.15% | Below 33% | Interest-bearing debt is just 7.1% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 42.62% | Below 49% | Money owed to the company is 42.6% of assets, under the 49% limit. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
NCS Multistage clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
2026-09-24
Clears
NCS Multistage clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 7%, inside the ~33% line, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value under review. Its inputs are 13 days old; there is no analyst estimate to cross-check it. We show no fair value, margin of safety or value read built on it until the review clears.
How a fair value is estimated: discounted cash flow (DCF).
Price History & ProjectionsWhere our models see it going: no fair-value estimate yet, range not available, dated to the 2026-10-23 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words| Forward P/E | 18.6xexpensive even after accounting for its growth |
| Trailing P/E | 10.8xreasonably valued |
| EPS, trailing | 4.94 |
| EPS, forward | 2.87 |
| Revenue growth | +5.2%slow but positive growth |
| Profit margin | 7.6%thin but positive margins |
| Return on equity | 14.0%a solid return on shareholder capital |
| FCF yield | 11.13% |
| Debt to equity | 0.09minimal debt: a conservative balance sheet |
| Current ratio | 4.27comfortably covers its short-term bills |
| Beta | 0.21barely tracks the market's swings |
| Short interest, float | 0.05% |
| 52-week range | 34.06 - 87.36 |
| Moat | NONE |
| Market cap | $140M |
| Employees | 272 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeNCSM trades on NASDAQ. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
2026-11-01
Accumulation $53.35
+0.0% Entry 8
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Over the past year the shares are up 80%. Our forward projection puts the odds of a 10% gain over the next month near 43%.
2026-10-20
Accumulation $53.35
+0.0% Entry 7
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Over the past year the shares are up 80%. Our forward projection puts the odds of a 10% gain over the next month near 43%.
2026-10-02
Accumulation $53.35
+0.0% Entry 6
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 20% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 80%. Our forward projection puts the odds of a 10% gain over the next month near 43%.
2026-09-06
Accumulation · changed $53.35
+22.4% Entry 5
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 22.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 20% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 80%. Our forward projection puts the odds of a 10% gain over the next month near 43%.
2026-08-06
Markup $43.59
-19.8% Entry 4
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 19.8% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 20% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 80%. Our forward projection puts the odds of a 10% gain over the next month near 43%.
2026-07-18
Markup $54.33
+0.0% Entry 3
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 20% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 80%. Our forward projection puts the odds of a 10% gain over the next month near 43%.
2026-07-03
Markup $54.33
+0.0% Entry 2
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
2026-07-02
Markup $54.33
Entry 1
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Weatherford and NCS Multistage Announce Anticipated Election Deadline and Closing Date Yahoo Finance · 24 Aug 2026
- NCS Multistage (NCSM) Reports Q2 Loss, Beats Revenue Estimates Zacks · 30 Jul 2026
- NCS Multistage (NCSM) Reports Q2 Loss, Beats Revenue Estimates Yahoo Finance · 30 Jul 2026
- NCS Multistage Holdings, Inc. Announces Second Quarter 2026 Results Yahoo Finance · 30 Jul 2026
- NCS Multistage Holdings, Inc. to Announce Second Quarter 2026 Financial Results on July 30, 2026 Yahoo Finance · 23 Jul 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
DWSNDawson Geophysical Company
NINENine Energy Service Inc
OMSEOMS Energy Technologies Inc
SNDSmart Sand Inc
HMHHMH Holding Inc.
DTIDrilling Tools International Corp
Screened names in the same industry · explore each on its own page.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-05-08 | Ro Khanna | Democrat | buy | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $42.05 | +27.1% | · | $1,271 | +27.1% |
| 2 months | $63.16 | -15.4% | · | $846 | -15.4% |
| 3 months | $64.68 | -17.4% | · | $826 | -17.4% |
| 6 months | $41.97 | +27.3% | · | $1,273 | +27.3% |
| 1 year | $29.61 | +80.5% | · | $1,805 | +80.5% |
| 2 years | $17.11 | +212.3% | · | $3,123 | +212.3% |
| 3 years | $17.74 | +201.2% | · | $3,012 | +201.2% |
| 5 years | $30.54 | +75.0% | · | $1,750 | +75.0% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever NCSM does next, these words stay.
Membership
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.